BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 1507493)

  • 1. [Quantitative analysis of urinary organic acid].
    Shimizu A; Nakanishi T
    Rinsho Byori; 1992 Jul; 40(7):743-50. PubMed ID: 1507493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reevaluation of optimum extraction condition for urinary organic acids using a stable isotope dilution technique].
    Nakanishi T; Shimizu A
    Rinsho Byori; 1992 Nov; 40(11):1161-7. PubMed ID: 1307622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical onset and prognosis of Asian children with organic acidemias, as detected by analysis of urinary organic acids using GC/MS, instead of mass screening.
    Hori D; Hasegawa Y; Kimura M; Yang Y; Verma IC; Yamaguchi S
    Brain Dev; 2005 Jan; 27(1):39-45. PubMed ID: 15626540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis of inborn errors of metabolism using tandem mass spectrometry and gas chromatography mass spectrometry].
    Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Jin J; Gu XF
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2122-6. PubMed ID: 19080473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry in disorders of organic acid metabolism.
    Niwa T
    Clin Chim Acta; 1995; 241-242():293-384. PubMed ID: 8612342
    [No Abstract]   [Full Text] [Related]  

  • 6. Automated, simplified GC/MS data processing system for organic acidemia screening and its application.
    Yamaguchi S; Kimura M; Iga M; Fu XW; Ohie T; Yamamoto T
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():174-80. PubMed ID: 11400763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypocitrullinemia in expanded newborn screening by LC-MS/MS is not a reliable marker for ornithine transcarbamylase deficiency.
    Cavicchi C; Malvagia S; la Marca G; Gasperini S; Donati MA; Zammarchi E; Guerrini R; Morrone A; Pasquini E
    J Pharm Biomed Anal; 2009 Jul; 49(5):1292-5. PubMed ID: 19359120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Variability of enzyme activity and urinary orotic acid in ornithine transcarbamylase deficient spf/+ heterozygotic mice].
    Qureshi IA; Letarte J; Lebel S; Ouellet R
    Diabete Metab; 1986 Oct; 12(5):250-5. PubMed ID: 3803679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a molecular understanding of ornithine transcarbamylase deficiency.
    Fox JE; Rosenberg LE
    Adv Neurol; 1988; 48():71-81. PubMed ID: 2891259
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of 3-hydroxyisovalerylcarnitine and other acylcarnitine levels using liquid chromatography-tandem mass spectrometry in serum and urine of a patient with multiple carboxylase deficiency.
    Maeda Y; Ito T; Ohmi H; Yokoi K; Nakajima Y; Ueta A; Kurono Y; Togari H; Sugiyama N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):154-9. PubMed ID: 18088573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperammonemia in the newborn through ornithine transcarbamylase deficiency (author's transl)].
    Plöchl E; Hilbe W; Bachmann C
    Padiatr Padol; 1981; 16(2):179-88. PubMed ID: 7243329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful living-donor liver transplantation from an asymptomatic carrier mother in ornithine transcarbamylase deficiency.
    Nagasaka H; Yorifuji T; Egawa H; Kikuta H; Tanaka K; Kobayashi K
    J Pediatr; 2001 Mar; 138(3):432-4. PubMed ID: 11241058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organic acid disorders detected by urine organic acid analysis: twelve cases in Thailand over three-year experience.
    Wasant P; Liammongkolkul S; Kuptanon C; Vatanavicharn N; Sathienkijakanchai A; Shinka T
    Clin Chim Acta; 2008 Jun; 392(1-2):63-8. PubMed ID: 18339316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ornithine transcarbamylase deficiency. Biochemical studies in the diagnosis of 4 cases and the identification of carriers].
    Briones Godino P; Vilaseca Busca MA; Alvarez Dominguez L; Rodes Monegal M; Campistol Plana J
    An Esp Pediatr; 1991 May; 34(5):360-4. PubMed ID: 1883110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a cytogenetic deletion and of four novel mutations (Q69X, I172F, G188V, G197R) affecting the gene for ornithine transcarbamylase (OTC) in Spanish patients with OTC deficiency.
    Climent C; García-Pérez MA; Sanjurjo P; Ruiz-Sanz JI; Vilaseca MA; Pineda M; Campistol J; Rubio V
    Hum Mutat; 1999 Oct; 14(4):352-3. PubMed ID: 10502831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sparse fur mouse as a model for gene therapy in ornithine carbamoyltransferase deficiency.
    Batshaw ML; Yudkoff M; McLaughlin BA; Gorry E; Anegawa NJ; Smith IA; Hyman SL; Robinson MB
    Gene Ther; 1995 Dec; 2(10):743-9. PubMed ID: 8750014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seven new mutations in the human ornithine transcarbamylase gene.
    Tuchman M; Plante RJ; McCann MT; Qureshi AA
    Hum Mutat; 1994; 4(1):57-60. PubMed ID: 7951259
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ornithine transcarbamylase deficiency (OTCD)].
    Matsuura T; Matsuda I
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):170-4. PubMed ID: 9590019
    [No Abstract]   [Full Text] [Related]  

  • 19. The phenotype of ostensibly healthy women who are carriers for ornithine transcarbamylase deficiency.
    Maestri NE; Lord C; Glynn M; Bale A; Brusilow SW
    Medicine (Baltimore); 1998 Nov; 77(6):389-97. PubMed ID: 9854602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic and late-onset ornithine transcarbamylase deficiency caused by a A208T mutation: clinical, biochemical and DNA analyses in a four-generation family.
    Ausems MG; Bakker E; Berger R; Duran M; van Diggelen OP; Keulemans JL; de Valk HW; Kneppers AL; Dorland L; Eskes PF; Beemer FA; Poll-The BT; Smeitink JA
    Am J Med Genet; 1997 Jan; 68(2):236-9. PubMed ID: 9028466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.